Author Question: A nurse is preparing to administer an antiarrhythmic and identifies the drug as a class III ... (Read 72 times)

cartlidgeashley

  • Hero Member
  • *****
  • Posts: 572
A nurse is preparing to administer an antiarrhythmic and identifies the drug as a class III potassium channel blocker. Which drug would the nurse be most likely to administer?
 
  A) Amiodarone
  B) Flecainide
  C) Mexiletine
  D) Propafenone

Question 2

A client is admitted to the cardiology unit of a health care facility for ventricular arrhythmia. In which of the following conditions can an antiarrhythmic drug be safely administered?
 
  A) Aortic stenosis
  B) Premature ventricular contraction
  C) Third-degree heart block
  D) Severe heart failure



ktidd

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

Ans: A
Feedback:
Amiodarone is a class III potassium channel blocker. Flecainide, mexiletine, and propafenone are class I sodium channel blockers.

Answer to Question 2

Ans: B
Feedback:
The nurse can safely administer an antiarrhythmic drug if the client has premature ventricular contractions. Aortic stenosis, third-degree heart block, and severe congestive heart failure are contraindications for the use of antiarrhythmic drugs.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library